- Home
- DENN vs PRQR Comparison
DENN vs PRQR Comparison
Compare DENN & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DENN
- PRQR
- Stock Information
- Founded
- DENN 1953
- PRQR 2012
- Country
- DENN United States
- PRQR Netherlands
- Employees
- DENN N/A
- PRQR N/A
- Industry
- DENN Restaurants
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- DENN Consumer Discretionary
- PRQR Health Care
- Exchange
- DENN Nasdaq
- PRQR Nasdaq
- Market Cap
- DENN 203.4M
- PRQR 179.1M
- IPO Year
- DENN 1989
- PRQR 2014
- Fundamental
- Price
- DENN $4.02
- PRQR $2.45
- Analyst Decision
- DENN Strong Buy
- PRQR Strong Buy
- Analyst Count
- DENN 6
- PRQR 8
- Target Price
- DENN $7.46
- PRQR $8.88
- AVG Volume (30 Days)
- DENN 638.8K
- PRQR 365.1K
- Earning Date
- DENN 07-29-2025
- PRQR 08-07-2025
- Dividend Yield
- DENN N/A
- PRQR N/A
- EPS Growth
- DENN N/A
- PRQR N/A
- EPS
- DENN 0.33
- PRQR N/A
- Revenue
- DENN $453,997,000.00
- PRQR $21,212,711.00
- Revenue This Year
- DENN $7.51
- PRQR N/A
- Revenue Next Year
- DENN $1.98
- PRQR N/A
- P/E Ratio
- DENN $12.65
- PRQR N/A
- Revenue Growth
- DENN N/A
- PRQR 85.91
- 52 Week Low
- DENN $2.85
- PRQR $1.07
- 52 Week High
- DENN $7.73
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- DENN 48.24
- PRQR 71.45
- Support Level
- DENN $4.04
- PRQR $2.10
- Resistance Level
- DENN $4.48
- PRQR $2.42
- Average True Range (ATR)
- DENN 0.21
- PRQR 0.14
- MACD
- DENN -0.02
- PRQR 0.02
- Stochastic Oscillator
- DENN 28.57
- PRQR 73.17
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.